QA: RenovoRx Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001574094_2023_RenovoRx_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001574094, RenovoRx Inc.

  xvar xval
0 AssetsCurrent 7,265,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 534,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 568,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,649,000
9 ResearchAndDevelopmentExpense 4,301,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 61,000
13 remainder_ComprehensiveNetIncome 17,000
  yvar yval
0 Assets 7,265,000
1 Liabilities 1,102,000
2 Expenses 9,950,000
3 Revenues 0
4 StockholdersEquity 6,163,000
5 NetIncome -9,889,000
6 ComprehensiveNetIncome -9,880,500
7 BaseVar 9,197,500
8 EconomicCapitalRatio 0.172

Edgar->Model Mapping

Feature Distribution

Change over Time